Research map: Elevated FN14 expression promotes proliferation, chemoresistance, and impairment of differentiation in rhabdomyosarcoma

Back to the article

Papers in this map

  1. Mitochondria as multifaceted regulators of cell death · Florian J. Bock · 2019 · 2535 citations · Cited by this paper
  2. Commentary regarding “Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study” · 2026 · Related
  3. Mitochondrial dysfunction: mechanisms and advances in therapy · Zong Yao · 2024 · 1152 citations · Cited by this paper
  4. Optimized L1CAM-CAR T cells enhance activity against moderate-antigen-density rhabdomyosarcoma models · 2026 · Related
  5. Rhabdomyosarcoma · Stephen X. Skapek · 2019 · 894 citations · Cited by this paper
  6. VG161 oncolytic virus remodels the tumor microenvironment by expanding CD3+ macrophages and enhancing antitumor immunity · 2026 · Related
  7. The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting · Jeffrey A. Winkles · 2008 · 611 citations · Cited by this paper
  8. GSN liquid-liquid phase separation induces PANoptosis by inhibiting YAP-dependent glycolysis to alleviate the progression of clear cell renal cell carcinoma · 2026 · Related
  9. Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft‐tissue Sarcoma committee experience and rationale for current COG studies · Suman Malempati · 2012 · 426 citations · Cited by this paper
  10. Mechano-activation of osteocytic connexin hemichannels prime microenvironment in suppressing breast cancer bone metastasis · 2026 · Related
  11. Apoptosis, Pyroptosis, and Necroptosis—Oh My! The Many Ways a Cell Can Die · Natália Ketelut-Carneiro · 2021 · 420 citations · Cited by this paper
  12. The m6A epitranscriptome in cancer therapy resistance: From cellular plasticity and metabolic rewiring to immune escape and therapeutic targeting · 2026 · Related
  13. Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma · Xiang 'Anthony' Chen · 2013 · 312 citations · Cited by this paper
  14. Targeting MDA-9/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells · 2026 · Related
  15. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial · Gianni Bisogno · 2019 · 254 citations · Cited by this paper
  16. Antibody-drug conjugates against multidrug-resistant cancers: Biomarker-guided patient selection, payload engineering, linker chemistry, and bystander effects · 2026 · Related
  17. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses · Linda C. Burkly · 2011 · 212 citations · Cited by this paper
  18. Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer · 2026 · Related
  19. Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer · Anne Birgitte Als · 2007 · 207 citations · Cited by this paper
  20. Early-onset lung cancer: etiologic heterogeneity, genomic features, and age-informed clinical management · 2026 · Related
  21. Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas · Douglas S. Hawkins · 2012 · 199 citations · Cited by this paper
  22. Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-κB and Correlate with Poor Patient Outcome · Nhan L. Tran · 2006 · 192 citations · Cited by this paper
  23. Tumor Necrosis Factor-like Weak Inducer of Apoptosis Inhibits Skeletal Myogenesis through Sustained Activation of Nuclear Factor-κB and Degradation of MyoD Protein · Charu Dogra · 2006 · 160 citations · Cited by this paper
  24. MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma · Marielle E. Yohe · 2018 · 155 citations · Cited by this paper
  25. Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo · Jane Renshaw · 2013 · 154 citations · Cited by this paper
  26. Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems · Venkatesh Prasanna Kashi · 2015 · 130 citations · Cited by this paper
  27. Mechanisms of impaired differentiation in rhabdomyosarcoma · Charles Keller · 2013 · 120 citations · Cited by this paper
  28. Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis · Sisi Wang · 2006 · 120 citations · Cited by this paper
  29. Signaling pathways in Rhabdomyosarcoma invasion and metastasis · Farah Ramadan · 2020 · 89 citations · Cited by this paper
  30. The Fibroblast Growth Factor–Inducible 14 Receptor Is Highly Expressed in HER2-Positive Breast Tumors and Regulates Breast Cancer Cell Invasive Capacity · Amanda L. Willis · 2008 · 87 citations · Cited by this paper
  31. TWEAK and cIAP1 Regulate Myoblast Fusion Through the Noncanonical NF-κB Signaling Pathway · Emeka K. Enwere · 2012 · 86 citations · Cited by this paper
  32. Rhabdomyosarcoma: Current Challenges and Their Implications for Developing Therapies · Simone Hettmer · 2014 · 84 citations · Cited by this paper
  33. Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies · Ali Zarrabi · 2023 · 83 citations · Cited by this paper
  34. Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms · Patricia Culp · 2010 · 82 citations · Cited by this paper
  35. Recent Advances and Challenges in the Treatment of Rhabdomyosarcoma · Shinji Miwa · 2020 · 82 citations · Cited by this paper
  36. Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS · Roberta Ciarapica · 2014 · 72 citations · Cited by this paper
  37. The TWEAK-Fn14 pathway: A potent regulator of skeletal muscle biology in health and disease · Marjan M. Tajrishi · 2013 · 71 citations · Cited by this paper
  38. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome · Mingguo Huang · 2011 · 61 citations · Cited by this paper
  39. Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma · George S. Watts · 2007 · 58 citations · Cited by this paper

Source: OpenAlex (CC0)